Ohio Product Liability Lawyer representing plaintiffs nationwide in Pharmaceutical Litigation and drug injury cases
When drugs are defective or ineffective in their intended uses, injuries may result, including birth defects, cardiac risks, amputation, internal bleeding, toxicity, and other injuries. Dangerous side effects can lead to serious complications and death.
It is prudent to contact your doctor after an injury and call an Ohio defective drug lawyer for a free consultation. The Lyon Firm has the legal resources and works with product liability experts to build the strongest case possible.
Drug companies ought to be held accountable for injuries linked to defective medications, and victims of drug injury should contact an attorney to weigh their legal options.
Product liability lawsuits and class action claims can bring in sizable settlements, and plaintiffs can benefit and seek compensation for medical expenses, pain and suffering, long-term disability, and other damages.
Every drug injury case is unique and Joe Lyon takes the time to review viable personal injury cases for plaintiffs nationwide. The Lyon Firm is dedicated to both plaintiffs well-being and the future of consumer safety.
Pharmaceutical Injury Lawsuits
The decision to take a pharmaceutical drug and to alter the balance of chemicals in our body is a serious decision that requires full understanding of the risk and benefits of taking the medication. It is equally, or even more critical, that our physician understands the full risks and benefits of a medication before prescribing a drug to a patient.
Prescription error is about the lack of disclosure by a pharmaceutical company related to the risks of injury from taking the medication. Pharmaceutical litigation seeks to obtain compensation for the economic and human losses that are suffered when the drug companies breach their duties and obligation to properly inform the medical community and patients of critical adverse side effects associated with the medication.
In past litigation, it has been discovered that drug companies often delay adding serious side effects to a drug’s label due to concerns about the impact on the sales and marketing.
If a drug carries more serious side effects, physicians and patients look for alternative treatments with less risk and the same or similar benefit. As a result, there is a financial incentive not to strengthen the warning label.
However, the label is the source of information that physicians and patients rely upon when making these important health decisions. There is no excuse for a company not to update its label when the science is sufficient to show an association with the medication.
Joe Lyon is a highly-rated Cincinnati Recall Lawyer and Ohio pharmaceutical product liability attorney who has successfully represented over a thousand plaintiffs injured by pharmaceutical products throughout the United States.
If you have questions about pharmaceutical litigation, contact The Lyon Firm for a no-obligation and confidential consultation.
Ohio Drug Litigation
The Lyon Firm is reviewing drug injury cases involving a wide range of pharmaceuticals currently on the market. Some of the drugs have been recalled, and some have only been tagged with additional warnings on the health risks they present. Some drugs that could be present health risks include:
- Montelukast (Singulair)
- Testosterone Replacement Therapy
Prescription Whistleblower Lawsuits
In recent years, doctors and drug companies have had a relationship that could be described as far too close. In fact, due to drug and medical device kickbacks, many doctors and medical companies have been named in medical fraud lawsuits.
Healthcare whistleblowers have been courageous and come forward with information that recovered a great deal of money for state programs like Medicare and Medicaid.
This area of law is a subset of the larger area of pharmaceutical litigation, though it plays an important role in understanding how the industry operates. The healthcare system is a profit-based industry that relies heavily on the growth of sales. The only way for some companies to grow their business is to sell as many pharmaceuticals as possible, even at the cost of consumer health.
The current opioid crisis is a good example of how over-prescribing medications can lead to a huge public health crisis. Pain medications have been a great tool for physicians in treating a wide variety of conditions, however, the abuse of prescribing and using pain medication has turned into one of biggest areas of pharmaceutical litigation today.
It is not only opioids that have been prescribed in huge numbers. Other drugs that have only been tested in short trials are released to the market each year and injure patients. A few examples of drug injury:
Testosterone: Low T clinics are under investigation after many patients receiving testosterone therapy have reported strokes and heart attacks. Experts say doctors may be pushing the therapy when not every aging man requires testosterone therapy.
Antibiotics: Antibiotic injuries are being reported at record rates as the drugs are prescribed more than ever before. Drug resistance and drug injury rates are on the rise, concerning the medical community and consumer protection attorneys.
Diabetes Drug Injury: Severe side effects are being reported by diabetes patients taking Invokana and other diabetes medications. Amputations and gangrene cases have opened the eyes of many taking the drugs, and lawsuits have been filed on their behalf.
Drug Contamination: Valsartan and Losartan contamination cases have raised the risk of patient cancer. Drug companies have failed to control the production process and put consumers at unnecessary risk.
Opioid Painkiller Lawsuits: Purdue Pharma, Johnson & Johnson and other large drug companies are deep in pharmaceutical settlement talks many years after the beginning of the opioid addiction crisis. Thousands of Americans die each year in opioid-related overdose deaths, many of which begin with doctors over-prescribing pain medications.
Pharmaceutical insurance kickbacks and pharmacy negligence has contributed to thousands of cases of drug injury and addiction. The Lyon Firm and other drug malpractice law firms are dedicated to making the health industry accountable for negligence.
A safer medical future is not too much to ask, and by filing a claim with an experienced attorney can help to ensure drug companies comply with consumer safety laws. As a plaintiff, you may be eligible for compensation to help pay for medical expenses, lost wages, pain and suffering and other damages.
Depo Provera: Confidential settlement from Pfizer to resolve all of the claims currently pending in the New Jersey State coordinated litigation. Joseph Lyon represented 13 females who suffered osteoporosis due to the failure of Pfizer to properly warn them and their physicians.
Seroquel: AstraZeneca resolved claims for $198 Million regarding claims that the company failed to warn about risks of diabetes and excessive weight gain. The Lyon Firm participated in this settlement and represented numerous claimants. In addition to the individual claims, Federal prosecutors and authorities from several U.S. states investigated whether AstraZeneca promoted Seroquel off-label, or for uses not approved by the U.S. Food and Drug Administration. The company announced a settlement of $520 million with the U.S. Justice Department over the matter.
Trasylol: Bayer resolved certain claims for $60 Million for patients who suffered heart failure and death as a result of the drug Trasylol. Trasylol was a drug used to prevent excessive bleeding during heart surgery. The science unequivocally showed Trasylol can cause kidney damage, heart failure and strokes, and greatly increase patients’ risk of post-surgery death when compared to rival treatments.
In 2006, a study by Dr. Dennis Mangano was published in the New England Journal of Medicine concluding that the drug more than doubled the risk of renal failure. After fourteen years on the market, Bayer suspended sales in November 2007. The Lyon Firm participated in this settlement.
Vioxx: Merck settled the outstanding Vioxx claims for $4.85 billion. The Lyon Firm participated in this settlement. In 2004, after a study showed Vioxx doubled the risk of heart attacks and strokes, Merck pulled Vioxx from the market. The case was then litigated with 16 trial ultimately going to the jury for a decision. Merck prevailed in 11 of the 16 trials.
Despite the settlement, Merck has not admitted that that Vioxx caused injuries. Each claim under the settlement was analyzed under an protocol that weighed such factors as a user’s age, their length of use, and their health risks such as obesity or hypertension. The individual extraordinary payout for a heart attack case was capped at $600,000.
Class Action Lawsuits & MDL Cases
Pharmaceutical litigation is a complex area of law that combines dense regulation, developing science, and multi-jurisdictional questions of law. Most cases involving claims of drug injury and pharmaceuticals become centralized in the federal multidistrict litigation process. Pharmaceutical litigation involving injury claims are not in most cases not class action lawsuits, but they are very similar.
Due to the volume of cases and number of similar issues, most pharmaceutical cases are handled through Multidistrict Litigation (MDL). The multidistrict litigation procedure is guided by the Judicial Panel for Multidistrict Litigation, where the case is centralized before one federal Judge for the purposes of pre-trial discovery.
The MDL process is appropriate where there are one or more common questions of fact in multiple cases pending in different federal district courts. While there often are parallel state consolidated proceedings, the federal MDL process is generally supported by both Plaintiff and Defendants in these cases.
The MDL process allows for efficiency where there are millions of pages of documents, many expert witnesses across multiple disciplines from epidemiology, pharmacology, toxicology and the specific discipline for the relevant mechanism of injury.
Pharmaceutical Lawsuits & FDA Oversight
Most experts would agree that the FDA is not designed nor does it have the resources to monitor every product through the post approval process once it has been granted clearance.
Very simply, the volume of medical devices that are presented for review is too demanding, so, while the FDA is a good initial step in the process, the responsibility of providing safe and effective pharmaceutical companies remains on the companies that profit from the sales.
While the pharmaceutical companies have yielded more influence over the review process, ultimately, the law is very clear that it is the company’s responsibility to run the appropriate tests, track the data, and to identify the side effects and then warn consumers and physicians adequately and in a timely manner.
Government approval is not a shield for liability. The Failure to timely and sufficiently warn of side effects operates as the primary cause of action for pharmaceutical claims.
Most importantly, the FDA and the government do not provide for compensation when someone is injured by a pharmaceutical product. The civil justice system provides the means for an individual harmed by a pharmaceutical product to obtain justice and recover for the losses suffered.
Without the civil justice system, companies would not be required to pay for the harm they cause, and the public tax system, in terms of Medicare and Medicaid, would have to absorb that loss. In other words, without pharmaceutical lawsuits, the tax payers would pay for corporate malfeasance and neglect.
Drug Injury & Patient Depression
A recent study published by the American Medical Association studied the close association between prescribed pharmaceutical drugs and related depression that results. The study highlighted depression as a potential adverse effect for many patients taking one or more prescription drugs.
Some patients may not be properly diagnosed with certain depressive disorders before they are given drugs by physicians, and others develop depression symptoms after taking the drugs for a short or prolonged period of time.
The JAMA study, conducted between 2005 and 2014, estimates that over 37 percent of adults are taking prescriptions drugs that carry the risk of depression as a side effect. Several medications are known to raise the risk of depression, including heartburn drugs (proton-pump inhibitors) and SSRI drugs meant to treat depressive disorders.
Researchers looked at prescription drugs that list depression and suicidal thoughts or behaviors as potential adverse side effects, as well as surveyed thousands of patients about their medications. The study concluded that patients have an increased risk of developing depression, but may or may not be warned by the physician or drug maker about the risks.
For those taking more than one, or more than three prescription drugs, the risk of depression rises dramatically. The research acknowledged that some patients may have a predisposition to depression before a course of drugs, though the risk still increased for those with or without a history of depression.
Recent studies have been concerned with the risks of polypharmacy—taking more than one prescription drug at a time. The number of patients taking more than three or five drugs at once is now a sizeable portion of the American population. Elderly Americans are the most likely to have multiple prescriptions, and also a large number of those suffering from depression.
Some expert and drug injury lawyer statements and allegations have argued that doctors and drug companies are aware that multiple prescriptions are not in a patient’s best interest, and yet the practice of multiple prescription is alive and well. The results can be severe, and injuries including depression can have devastating consequences.
When drug makers and large corporations are negligent and produce dangerous products that lead to serious illness and injury, legal action can be necessary. In the current corporate environment, filing lawsuits is one of the only ways to keep drug companies from selling untested and dubious pharmaceuticals in the name of profit.
By taking the initiative and filing drug injury lawsuits, plaintiffs can receive proper compensation and hold a corporation accountable for their negligent actions. Consumer safety depends largely on making sure companies operate within the law and within ethical boundaries.
Drug Injury Attorney
Following a drug injury that could have been prevented, victims and their families should consider hiring an experienced drug injury lawyer to investigate. Overmedicating and Medical Negligence as well as drug manufacturers, may be liable for drug-associated depression.
Plaintiffs are encouraged to hold negligent parties accountable, and in the process may be eligible for large settlements and compensation for depression treatment, medical costs, and pain and suffering.
If you or a loved one has suffered an injury due to pharmaceutical injury or hospital negligence, and have questions about the root cause and the legal remedies available to improve quality of life and medical care in Ohio, contact The Lyon Firm at (800) 513-2403. You will speak directly with Mr. Lyon, and he will help you answer these critical questions regarding Pharmaceutical litigation.